Key facts
- It has raised $3.8M; the latest was Early Stage VC ($2.7M) in Jul 2025.
- Notable investors include DOMO.VC, 1616 Ventures, Aggir Ventures, Astella Investimentos, Iporanga Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Cienty
- ·The full record, as it builds
Funding rounds
No funding rounds for Cienty are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cienty
Developer of a B2B marketplace designed to streamline purchasing and distribution across the pharmaceutical retail chain. The company offers a platform with purchasing management tools, AI-driven product recommendations, partner network access, and real-time pricing, enabling independent pharmacies, wholesalers, and manufacturers to operate efficiently, increase margins, and reach underserved markets.
- Sector
- Information Technology
- HQ
- Sao Paulo, Brazil
- Founded
- 2022
- Employees
- 20
- Website
- cienty.com.br/
- Ownership
- Privately Held (backing)
Cienty doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cienty shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cienty in its N-PORT filings yet. We sweep new filings monthly.